Home › Targets › MEK 2

MEK 2 (1 companies · 2 programs)

Companies with an active program directed at MEK 2.

Pasithea Therapeutics Corp. KTTA

PAS-004 — Neurofibromatosis Type 1 Phase 1
PAS-004 — Advanced Solid Tumors Phase 1